|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:OGT-DMXL1 (FusionGDB2 ID:61038) |
Fusion Gene Summary for OGT-DMXL1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: OGT-DMXL1 | Fusion gene ID: 61038 | Hgene | Tgene | Gene symbol | OGT | DMXL1 | Gene ID | 8473 | 1657 |
Gene name | O-linked N-acetylglucosamine (GlcNAc) transferase | Dmx like 1 | |
Synonyms | HINCUT-1|HRNT1|MRX106|O-GLCNAC|OGT1 | - | |
Cytomap | Xq13.1 | 5q23.1 | |
Type of gene | protein-coding | protein-coding | |
Description | UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitO-GlcNAc transferase p110 subunitO-GlcNAc transferase subunit p110O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminy | dmX-like protein 1 | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | Q9Y485 | |
Ensembl transtripts involved in fusion gene | ENST00000373719, ENST00000373701, ENST00000498566, | ENST00000311085, ENST00000539542, ENST00000505312, | |
Fusion gene scores | * DoF score | 9 X 9 X 4=324 | 4 X 5 X 4=80 |
# samples | 10 | 5 | |
** MAII score | log2(10/324*10)=-1.6959938131099 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: OGT [Title/Abstract] AND DMXL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | OGT(70784603)-DMXL1(118582689), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | OGT-DMXL1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. OGT-DMXL1 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. OGT-DMXL1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | OGT | GO:0006110 | regulation of glycolytic process | 22923583 |
Hgene | OGT | GO:0006493 | protein O-linked glycosylation | 21240259|21285374|22923583|23222540|23352454|24474760 |
Hgene | OGT | GO:0006915 | apoptotic process | 20824293 |
Hgene | OGT | GO:0032868 | response to insulin | 18288188 |
Hgene | OGT | GO:0035020 | regulation of Rac protein signal transduction | 18288188 |
Hgene | OGT | GO:0043981 | histone H4-K5 acetylation | 20018852 |
Hgene | OGT | GO:0043982 | histone H4-K8 acetylation | 20018852 |
Hgene | OGT | GO:0043984 | histone H4-K16 acetylation | 20018852 |
Hgene | OGT | GO:0045862 | positive regulation of proteolysis | 21285374 |
Hgene | OGT | GO:0045944 | positive regulation of transcription by RNA polymerase II | 23222540|23353889 |
Hgene | OGT | GO:0046626 | regulation of insulin receptor signaling pathway | 18288188 |
Hgene | OGT | GO:0048015 | phosphatidylinositol-mediated signaling | 18288188 |
Fusion gene breakpoints across OGT (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across DMXL1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | 173N | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
Top |
Fusion Gene ORF analysis for OGT-DMXL1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000373719 | ENST00000311085 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
Frame-shift | ENST00000373719 | ENST00000539542 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
5CDS-3UTR | ENST00000373719 | ENST00000505312 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
In-frame | ENST00000373701 | ENST00000311085 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
Frame-shift | ENST00000373701 | ENST00000539542 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
5CDS-3UTR | ENST00000373701 | ENST00000505312 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
intron-3CDS | ENST00000498566 | ENST00000311085 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
intron-3CDS | ENST00000498566 | ENST00000539542 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
intron-3UTR | ENST00000498566 | ENST00000505312 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000373719 | OGT | chrX | 70784603 | + | ENST00000311085 | DMXL1 | chr5 | 118582689 | + | 4939 | 2806 | 67 | 3030 | 987 |
ENST00000373701 | OGT | chrX | 70784603 | + | ENST00000311085 | DMXL1 | chr5 | 118582689 | + | 4869 | 2736 | 27 | 2960 | 977 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000373719 | ENST00000311085 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + | 0.000318881 | 0.9996811 |
ENST00000373701 | ENST00000311085 | OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + | 0.000364793 | 0.9996352 |
Top |
Fusion Genomic Features for OGT-DMXL1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + | 0.9896488 | 0.010351134 |
OGT | chrX | 70784603 | + | DMXL1 | chr5 | 118582689 | + | 0.9896488 | 0.010351134 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for OGT-DMXL1 |
Go to FGviewer for the breakpoints of chrX:70784603-chr5:118582689 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | DMXL1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 487_503 | 853.0 | 1037.0 | Motif | Nuclear localization signal |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 487_503 | 863.0 | 1047.0 | Motif | Nuclear localization signal |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 123_156 | 853.0 | 1037.0 | Repeat | Note=TPR 3 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 157_190 | 853.0 | 1037.0 | Repeat | Note=TPR 4 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 191_224 | 853.0 | 1037.0 | Repeat | Note=TPR 5 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 21_54 | 853.0 | 1037.0 | Repeat | Note=TPR 1 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 225_258 | 853.0 | 1037.0 | Repeat | Note=TPR 6 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 259_292 | 853.0 | 1037.0 | Repeat | Note=TPR 7 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 293_326 | 853.0 | 1037.0 | Repeat | Note=TPR 8 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 327_360 | 853.0 | 1037.0 | Repeat | Note=TPR 9 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 361_394 | 853.0 | 1037.0 | Repeat | Note=TPR 10 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 395_428 | 853.0 | 1037.0 | Repeat | Note=TPR 11 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 429_462 | 853.0 | 1037.0 | Repeat | Note=TPR 12 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 463_473 | 853.0 | 1037.0 | Repeat | Note=TPR 13%3B truncated |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 89_122 | 853.0 | 1037.0 | Repeat | Note=TPR 2 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 123_156 | 863.0 | 1047.0 | Repeat | Note=TPR 3 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 157_190 | 863.0 | 1047.0 | Repeat | Note=TPR 4 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 191_224 | 863.0 | 1047.0 | Repeat | Note=TPR 5 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 21_54 | 863.0 | 1047.0 | Repeat | Note=TPR 1 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 225_258 | 863.0 | 1047.0 | Repeat | Note=TPR 6 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 259_292 | 863.0 | 1047.0 | Repeat | Note=TPR 7 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 293_326 | 863.0 | 1047.0 | Repeat | Note=TPR 8 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 327_360 | 863.0 | 1047.0 | Repeat | Note=TPR 9 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 361_394 | 863.0 | 1047.0 | Repeat | Note=TPR 10 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 395_428 | 863.0 | 1047.0 | Repeat | Note=TPR 11 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 429_462 | 863.0 | 1047.0 | Repeat | Note=TPR 12 |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 463_473 | 863.0 | 1047.0 | Repeat | Note=TPR 13%3B truncated |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 89_122 | 863.0 | 1047.0 | Repeat | Note=TPR 2 |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2978_3016 | 2953.0 | 3028.0 | Repeat | Note=WD 16 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 906_908 | 853.0 | 1037.0 | Nucleotide binding | UDP |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 911_914 | 853.0 | 1037.0 | Nucleotide binding | UDP |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 930_932 | 853.0 | 1037.0 | Nucleotide binding | UDP |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 906_908 | 863.0 | 1047.0 | Nucleotide binding | UDP |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 911_914 | 863.0 | 1047.0 | Nucleotide binding | UDP |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 930_932 | 863.0 | 1047.0 | Nucleotide binding | UDP |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373701 | + | 19 | 22 | 991_1010 | 853.0 | 1037.0 | Region | Note=Required for phosphatidylinositol 3%2C4%2C5-triphosphate binding |
Hgene | OGT | chrX:70784603 | chr5:118582689 | ENST00000373719 | + | 19 | 22 | 991_1010 | 863.0 | 1047.0 | Region | Note=Required for phosphatidylinositol 3%2C4%2C5-triphosphate binding |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2459_2468 | 2953.0 | 3028.0 | Compositional bias | Note=Poly-Asp | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 108_145 | 2953.0 | 3028.0 | Repeat | Note=WD 1 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 1134_1175 | 2953.0 | 3028.0 | Repeat | Note=WD 9 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 1211_1251 | 2953.0 | 3028.0 | Repeat | Note=WD 10 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 166_206 | 2953.0 | 3028.0 | Repeat | Note=WD 2 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 229_277 | 2953.0 | 3028.0 | Repeat | Note=WD 3 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2742_2783 | 2953.0 | 3028.0 | Repeat | Note=WD 11 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2785_2824 | 2953.0 | 3028.0 | Repeat | Note=WD 12 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2836_2878 | 2953.0 | 3028.0 | Repeat | Note=WD 12 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2884_2923 | 2953.0 | 3028.0 | Repeat | Note=WD 14 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 2926_2965 | 2953.0 | 3028.0 | Repeat | Note=WD 15 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 476_516 | 2953.0 | 3028.0 | Repeat | Note=WD 4 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 580_621 | 2953.0 | 3028.0 | Repeat | Note=WD 5 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 628_665 | 2953.0 | 3028.0 | Repeat | Note=WD 6 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 848_895 | 2953.0 | 3028.0 | Repeat | Note=WD 7 | |
Tgene | DMXL1 | chrX:70784603 | chr5:118582689 | ENST00000311085 | 41 | 43 | 968_1010 | 2953.0 | 3028.0 | Repeat | Note=WD 8 |
Top |
Fusion Gene Sequence for OGT-DMXL1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000373719_ENST00000311085_173N_OGT_chrX_70784603_+_DMXL1_chr5_118582689_length(transcript)=4939nt_BP=2806nt GGCCGAGGAGCCGTCGCCGCCATTTCAAGACCGTACTAGGTAGATGGTCAATTAGAGTTCCCAGGGTTTGAAGCCTGTAACTGCTGCCGC CGCTCAAGCCCTCCAGAGCATTGCTACGGCTGCTGCCCTTGTACTACTACCTCCAAATACGTTCTTGCTGGTAGTGGCGGCAGCAGGACC AATTACCTCTTTTTTGCTCTCCCTCGAGAAGCTCCAGATGGCGTCTTCCGTGGGCAACGTGGCCGACAGCACAGAACCAACGAAACGTAT GCTTTCCTTCCAAGGGTTAGCTGAGTTGGCACATCGAGAATATCAGGCAGGAGATTTTGAGGCAGCTGAGAGACACTGCATGCAGCTCTG GAGACAAGAGCCAGACAATACTGGTGTGCTTTTATTACTTTCATCTATACACTTCCAGTGTCGAAGGCTGGACAGATCTGCTCACTTTAG CACTCTGGCAATTAAACAGAACCCCCTTCTGGCAGAAGCTTATTCGAATTTGGGGAATGTGTACAAGGAAAGAGGGCAGTTGCAGGAGGC AATTGAGCATTATCGACATGCATTGCGTCTCAAACCTGATTTCATCGATGGTTATATTAACCTGGCAGCCGCCTTGGTAGCAGCGGGTGA CATGGAAGGGGCAGTACAAGCTTACGTCTCTGCTCTTCAGTACAATCCTGATTTGTACTGTGTTCGCAGTGACCTGGGGAACCTGCTCAA AGCCCTGGGTCGCTTGGAAGAAGCCAAGGCATGTTATTTGAAAGCAATTGAGACGCAACCGAACTTTGCAGTAGCTTGGAGTAATCTTGG CTGTGTTTTCAATGCACAAGGGGAAATTTGGCTTGCAATTCATCACTTTGAAAAGGCTGTCACCCTTGACCCAAACTTTCTGGATGCTTA TATCAATTTAGGAAATGTCTTGAAAGAGGCACGCATTTTTGACAGAGCTGTGGCAGCTTATCTTCGTGCCCTAAGTTTGAGTCCAAATCA CGCAGTGGTGCACGGCAACCTGGCTTGTGTATACTATGAGCAAGGCCTGATAGATCTGGCAATAGACACCTACAGGCGGGCTATCGAACT ACAACCACATTTCCCTGATGCTTACTGCAACCTAGCCAATGCTCTCAAAGAGAAGGGCAGTGTTGCTGAAGCAGAAGATTGTTATAATAC AGCTCTCCGTCTGTGTCCCACCCATGCAGACTCTCTGAATAACCTAGCCAATATCAAACGAGAACAGGGAAACATTGAAGAGGCAGTTCG CTTGTATCGTAAAGCATTAGAAGTCTTCCCAGAGTTTGCTGCTGCCCATTCAAATTTAGCAAGTGTACTGCAGCAGCAGGGAAAACTGCA GGAAGCTCTGATGCATTATAAGGAGGCTATTCGAATCAGTCCTACCTTTGCTGATGCCTACTCTAATATGGGAAACACTCTAAAGGAGAT GCAGGATGTTCAGGGAGCCTTGCAGTGTTATACGCGTGCCATCCAAATTAATCCTGCATTTGCAGATGCACATAGCAATCTGGCTTCCAT TCATAAGGATTCAGGGAATATTCCAGAAGCCATAGCTTCTTACCGCACGGCTCTGAAACTTAAGCCTGATTTTCCTGATGCTTATTGTAA CTTGGCTCATTGCCTGCAGATTGTCTGTGATTGGACAGACTATGATGAGCGAATGAAGAAGTTGGTCAGTATTGTGGCTGACCAGTTAGA GAAGAATAGGTTGCCTTCTGTGCATCCTCATCATAGTATGCTATATCCTCTTTCTCATGGCTTCAGGAAGGCTATTGCTGAGAGGCACGG CAACCTGTGCTTAGATAAGATTAATGTTCTTCATAAACCACCATATGAACATCCAAAAGACTTGAAGCTCAGTGATGGTCGGCTGCGTGT AGGATATGTGAGTTCCGACTTTGGGAATCATCCTACTTCTCACCTTATGCAGTCTATTCCAGGCATGCACAATCCTGATAAATTTGAGGT GTTCTGTTATGCCCTGAGCCCAGACGATGGCACAAACTTCCGAGTGAAGGTGATGGCAGAAGCCAATCATTTCATTGATCTTTCTCAGAT TCCATGCAATGGAAAAGCAGCTGATCGCATCCATCAGGATGGAATTCATATCCTTGTAAATATGAATGGCTATACTAAGGGCGCTCGAAA TGAGCTTTTTGCTCTCAGGCCAGCTCCTATTCAGGCAATGTGGCTGGGATACCCTGGGACGAGTGGTGCGCTTTTCATGGATTATATTAT CACTGATCAGGAAACTTCGCCAGCTGAAGTTGCTGAGCAGTATTCCGAGAAATTGGCTTATATGCCCCACACTTTTTTTATTGGTGATCA TGCTAATATGTTCCCTCACCTGAAGAAAAAAGCAGTCATCGATTTTAAGTCCAATGGGCACATTTATGACAATCGGATAGTTCTGAATGG CATCGACCTCAAAGCATTTCTTGATAGTCTACCAGATGTGAAAATTGTCAAGATGAAGTGTCCTGATGGAGGAGACAATGCAGATAGCAG TAACACAGCTCTTAATATGCCTGTTATTCCTATGAATACTATTGCAGAAGCAGTTATTGAAATGATTAACCGAGGACAGATTCAAATAAC AATTAATGGATTCAGTATTAGCAATGGACTGGCAACTACTCAGATCAACAATAAGGCTGCAACTGGAGAGGAGGTTCCCCGTACCATTAT TGTAACCACCCGTTCTCAGTACGGGTTACCAGAAGATGCCATCGTATACTGTAACTTTAATCAGTTGTATAAAATTGACCCTTCTACTTT GCAGATGTGGGCAAACATTTGGAGTCTCTCTACCTTTGGTCTTCTCCATACTTTTGTCAGTGAACATGCTCGGCAGTCCATTTTTAGAAA TATTGGAACTGGAGTGATGCAAATTGAGACAGGGCCTGCAAATCACATTTTCTCCTGTGGAGCTGATGGAACAATGAAAATGAGAATACT GCCAGATCAGTTTAGCCCTTTAAATGAAGTGTTGAAAAATGATGTGAAATTTATGCTATAACATTTTTACAATAAGATGTACAATTTATT ACCTATATGGAAGTGGCCAACAGATATAATATACAGTGATCATTCTCTATGCCACAAATTAGCTAATGCTTTCTTGTTTTTATATTTATT TTATGGAGCTTTGCCCTTGATGCACTGATGCCTTAAAAATTAACAAGGTCATTCAGAAGTAGATTACATTGCCTAAAGTAGAATGTGTAA GTAATGCTGTAATAATACATATCATAGTATATTATAATCAGTATGTCATAGTGTTAAAGGTGTTTTGTTTTCTTATTGATACTTTTCCAC AGGCATCTCTGCATGAATTTCTTCCACAGTAAAAATACGTTTTTTGTAAAGGCAATTGTACATAATACTCATCACTTAATTCACCACACT CTCACTTCCTTTATTAGCCTTATACATCTCAAACTCTTCTCTTAATTAATGATAGGTATTTGAGTAAGAATGAAAAAAATAATGAACATC TTCATTAAAATTGTCATTGAGACGTCAGTGATAAATGAGCTAGATGGCTCAATATGTAAGGTTTTCAGTAGTTTACCCTCCGGAACCCAA GTTGTATGTATGTATACGTGTGTGTGTGTGTGTGTGTGTGTATCTTACACATCTTATTTGAACTTAGTTGTATATATTAGCGAAAACTGG TTTTTCATGTGTTTTTGTGCCATAACAACTATTGCCACCAGAATAACTTTTTTTTTGCAACTGTGCTTTTCATTTTTAAAAAATTTTTGA ATTCCCATCCTAATTTTCAAATAAGTTTCAAGGAGACTATCAGGATTATTATTTTAAAGATTAGATTTAGTCAAATAAGTCTTAGCAGGC AATAAAGTTTCTGTGGTGGCATATATCATGTAAGACACTTAAAGTAAGTTTGTGAATTTGTCAACTTTCGAGCATCAAACAAATATTTTA CTTAAATTTTATTTTATCTTATTTTTAGGTGCTTTTAATCTCAAAATTCTGAAAAGCGAATAGCAGTGTTTTCAGAAACAAATGTGAAAG CAGTCAAATTAAGTAGATACTATTTAGAAATGTAAAATACTCTCCAGATCTACCATTAATAGAAAATAAACTAAACCTTATATTTTATTT TTGCCAAAATATTTTATTATAAAATATGACCAAAATATTTAAAATGCACAATGCTTTTAACTTAAATGTGCTAACCCTGTTTCTGTCTGT TTTGTGCTGTACCTTTTCTGATTCAGAATTATAGAAAACTTGATAAATACTTGATTTTAACCAATGAGACTACAGGCAGATGGGACTAAG TGTTTATGGGACAATTATGTACTATTTAACTTAAATATATTTTGTTTAATAGGAAATATATAATAATAGCATTTTATGTAATAAAATATG GGCAACGATTATCTTGGAAATTAAAGAGTCAAAGCAAAGAAATGAAGGGCTGGTAAAATGAATTTTGTAATATCCTCAGGATACTTTTAT CTTAAAAGTATGTTGTTAAAGATTTTGTAAATTGTATTTCAACAATTTTAAATGTGTTGAGCAAGTTGCAGTGCAAACACTGTCATTATG TAGAGAGTTTATATGCACATAATAACCTGTACCTATAAATCGTGCAATAACCATATGCGACTATTTTGCCATGGAGAAATCTGACAGCAT TGCAAACAATAGTATTGTTTGATGTAGTTAACCTTAAGTTATTTTTCAGTAATTTCTTCACAAATCAAGATTCAAACAGCTTTAAACACT TCCAATGAGATAAAATATTTACTATTATGCTTATTAGAACAAAAGGTGTTTAAGGATGAACTAAATATTTTAATTGAGCATTTATATGGA >In-frame_ENST00000373719_ENST00000311085_173N_OGT_chrX_70784603_+_DMXL1_chr5_118582689_length(amino acids)=987AA_start in transcript=67_stop in transcript=3030 MKPVTAAAAQALQSIATAAALVLLPPNTFLLVVAAAGPITSFLLSLEKLQMASSVGNVADSTEPTKRMLSFQGLAELAHREYQAGDFEAA ERHCMQLWRQEPDNTGVLLLLSSIHFQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLA AALVAAGDMEGAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEAKACYLKAIETQPNFAVAWSNLGCVFNAQGEIWLAIHHFEKAVTL DPNFLDAYINLGNVLKEARIFDRAVAAYLRALSLSPNHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANALKEKGSVA EAEDCYNTALRLCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSN MGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLV SIVADQLEKNRLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGM HNPDKFEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNELFALRPAPIQAMWLGYPGTSG ALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPD GGDNADSSNTALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQL -------------------------------------------------------------- >In-frame_ENST00000373701_ENST00000311085_173N_OGT_chrX_70784603_+_DMXL1_chr5_118582689_length(transcript)=4869nt_BP=2736nt TAGATGGTCAATTAGAGTTCCCAGGGTTTGAAGCCTGTAACTGCTGCCGCCGCTCAAGCCCTCCAGAGCATTGCTACGGCTGCTGCCCTT GTACTACTACCTCCAAATACGTTCTTGCTGGTAGTGGCGGCAGCAGGACCAATTACCTCTTTTTTGCTCTCCCTCGAGAAGCTCCAGATG GCGTCTTCCGTGGGCAACGTGGCCGACAGCACAGGGTTAGCTGAGTTGGCACATCGAGAATATCAGGCAGGAGATTTTGAGGCAGCTGAG AGACACTGCATGCAGCTCTGGAGACAAGAGCCAGACAATACTGGTGTGCTTTTATTACTTTCATCTATACACTTCCAGTGTCGAAGGCTG GACAGATCTGCTCACTTTAGCACTCTGGCAATTAAACAGAACCCCCTTCTGGCAGAAGCTTATTCGAATTTGGGGAATGTGTACAAGGAA AGAGGGCAGTTGCAGGAGGCAATTGAGCATTATCGACATGCATTGCGTCTCAAACCTGATTTCATCGATGGTTATATTAACCTGGCAGCC GCCTTGGTAGCAGCGGGTGACATGGAAGGGGCAGTACAAGCTTACGTCTCTGCTCTTCAGTACAATCCTGATTTGTACTGTGTTCGCAGT GACCTGGGGAACCTGCTCAAAGCCCTGGGTCGCTTGGAAGAAGCCAAGGCATGTTATTTGAAAGCAATTGAGACGCAACCGAACTTTGCA GTAGCTTGGAGTAATCTTGGCTGTGTTTTCAATGCACAAGGGGAAATTTGGCTTGCAATTCATCACTTTGAAAAGGCTGTCACCCTTGAC CCAAACTTTCTGGATGCTTATATCAATTTAGGAAATGTCTTGAAAGAGGCACGCATTTTTGACAGAGCTGTGGCAGCTTATCTTCGTGCC CTAAGTTTGAGTCCAAATCACGCAGTGGTGCACGGCAACCTGGCTTGTGTATACTATGAGCAAGGCCTGATAGATCTGGCAATAGACACC TACAGGCGGGCTATCGAACTACAACCACATTTCCCTGATGCTTACTGCAACCTAGCCAATGCTCTCAAAGAGAAGGGCAGTGTTGCTGAA GCAGAAGATTGTTATAATACAGCTCTCCGTCTGTGTCCCACCCATGCAGACTCTCTGAATAACCTAGCCAATATCAAACGAGAACAGGGA AACATTGAAGAGGCAGTTCGCTTGTATCGTAAAGCATTAGAAGTCTTCCCAGAGTTTGCTGCTGCCCATTCAAATTTAGCAAGTGTACTG CAGCAGCAGGGAAAACTGCAGGAAGCTCTGATGCATTATAAGGAGGCTATTCGAATCAGTCCTACCTTTGCTGATGCCTACTCTAATATG GGAAACACTCTAAAGGAGATGCAGGATGTTCAGGGAGCCTTGCAGTGTTATACGCGTGCCATCCAAATTAATCCTGCATTTGCAGATGCA CATAGCAATCTGGCTTCCATTCATAAGGATTCAGGGAATATTCCAGAAGCCATAGCTTCTTACCGCACGGCTCTGAAACTTAAGCCTGAT TTTCCTGATGCTTATTGTAACTTGGCTCATTGCCTGCAGATTGTCTGTGATTGGACAGACTATGATGAGCGAATGAAGAAGTTGGTCAGT ATTGTGGCTGACCAGTTAGAGAAGAATAGGTTGCCTTCTGTGCATCCTCATCATAGTATGCTATATCCTCTTTCTCATGGCTTCAGGAAG GCTATTGCTGAGAGGCACGGCAACCTGTGCTTAGATAAGATTAATGTTCTTCATAAACCACCATATGAACATCCAAAAGACTTGAAGCTC AGTGATGGTCGGCTGCGTGTAGGATATGTGAGTTCCGACTTTGGGAATCATCCTACTTCTCACCTTATGCAGTCTATTCCAGGCATGCAC AATCCTGATAAATTTGAGGTGTTCTGTTATGCCCTGAGCCCAGACGATGGCACAAACTTCCGAGTGAAGGTGATGGCAGAAGCCAATCAT TTCATTGATCTTTCTCAGATTCCATGCAATGGAAAAGCAGCTGATCGCATCCATCAGGATGGAATTCATATCCTTGTAAATATGAATGGC TATACTAAGGGCGCTCGAAATGAGCTTTTTGCTCTCAGGCCAGCTCCTATTCAGGCAATGTGGCTGGGATACCCTGGGACGAGTGGTGCG CTTTTCATGGATTATATTATCACTGATCAGGAAACTTCGCCAGCTGAAGTTGCTGAGCAGTATTCCGAGAAATTGGCTTATATGCCCCAC ACTTTTTTTATTGGTGATCATGCTAATATGTTCCCTCACCTGAAGAAAAAAGCAGTCATCGATTTTAAGTCCAATGGGCACATTTATGAC AATCGGATAGTTCTGAATGGCATCGACCTCAAAGCATTTCTTGATAGTCTACCAGATGTGAAAATTGTCAAGATGAAGTGTCCTGATGGA GGAGACAATGCAGATAGCAGTAACACAGCTCTTAATATGCCTGTTATTCCTATGAATACTATTGCAGAAGCAGTTATTGAAATGATTAAC CGAGGACAGATTCAAATAACAATTAATGGATTCAGTATTAGCAATGGACTGGCAACTACTCAGATCAACAATAAGGCTGCAACTGGAGAG GAGGTTCCCCGTACCATTATTGTAACCACCCGTTCTCAGTACGGGTTACCAGAAGATGCCATCGTATACTGTAACTTTAATCAGTTGTAT AAAATTGACCCTTCTACTTTGCAGATGTGGGCAAACATTTGGAGTCTCTCTACCTTTGGTCTTCTCCATACTTTTGTCAGTGAACATGCT CGGCAGTCCATTTTTAGAAATATTGGAACTGGAGTGATGCAAATTGAGACAGGGCCTGCAAATCACATTTTCTCCTGTGGAGCTGATGGA ACAATGAAAATGAGAATACTGCCAGATCAGTTTAGCCCTTTAAATGAAGTGTTGAAAAATGATGTGAAATTTATGCTATAACATTTTTAC AATAAGATGTACAATTTATTACCTATATGGAAGTGGCCAACAGATATAATATACAGTGATCATTCTCTATGCCACAAATTAGCTAATGCT TTCTTGTTTTTATATTTATTTTATGGAGCTTTGCCCTTGATGCACTGATGCCTTAAAAATTAACAAGGTCATTCAGAAGTAGATTACATT GCCTAAAGTAGAATGTGTAAGTAATGCTGTAATAATACATATCATAGTATATTATAATCAGTATGTCATAGTGTTAAAGGTGTTTTGTTT TCTTATTGATACTTTTCCACAGGCATCTCTGCATGAATTTCTTCCACAGTAAAAATACGTTTTTTGTAAAGGCAATTGTACATAATACTC ATCACTTAATTCACCACACTCTCACTTCCTTTATTAGCCTTATACATCTCAAACTCTTCTCTTAATTAATGATAGGTATTTGAGTAAGAA TGAAAAAAATAATGAACATCTTCATTAAAATTGTCATTGAGACGTCAGTGATAAATGAGCTAGATGGCTCAATATGTAAGGTTTTCAGTA GTTTACCCTCCGGAACCCAAGTTGTATGTATGTATACGTGTGTGTGTGTGTGTGTGTGTGTATCTTACACATCTTATTTGAACTTAGTTG TATATATTAGCGAAAACTGGTTTTTCATGTGTTTTTGTGCCATAACAACTATTGCCACCAGAATAACTTTTTTTTTGCAACTGTGCTTTT CATTTTTAAAAAATTTTTGAATTCCCATCCTAATTTTCAAATAAGTTTCAAGGAGACTATCAGGATTATTATTTTAAAGATTAGATTTAG TCAAATAAGTCTTAGCAGGCAATAAAGTTTCTGTGGTGGCATATATCATGTAAGACACTTAAAGTAAGTTTGTGAATTTGTCAACTTTCG AGCATCAAACAAATATTTTACTTAAATTTTATTTTATCTTATTTTTAGGTGCTTTTAATCTCAAAATTCTGAAAAGCGAATAGCAGTGTT TTCAGAAACAAATGTGAAAGCAGTCAAATTAAGTAGATACTATTTAGAAATGTAAAATACTCTCCAGATCTACCATTAATAGAAAATAAA CTAAACCTTATATTTTATTTTTGCCAAAATATTTTATTATAAAATATGACCAAAATATTTAAAATGCACAATGCTTTTAACTTAAATGTG CTAACCCTGTTTCTGTCTGTTTTGTGCTGTACCTTTTCTGATTCAGAATTATAGAAAACTTGATAAATACTTGATTTTAACCAATGAGAC TACAGGCAGATGGGACTAAGTGTTTATGGGACAATTATGTACTATTTAACTTAAATATATTTTGTTTAATAGGAAATATATAATAATAGC ATTTTATGTAATAAAATATGGGCAACGATTATCTTGGAAATTAAAGAGTCAAAGCAAAGAAATGAAGGGCTGGTAAAATGAATTTTGTAA TATCCTCAGGATACTTTTATCTTAAAAGTATGTTGTTAAAGATTTTGTAAATTGTATTTCAACAATTTTAAATGTGTTGAGCAAGTTGCA GTGCAAACACTGTCATTATGTAGAGAGTTTATATGCACATAATAACCTGTACCTATAAATCGTGCAATAACCATATGCGACTATTTTGCC ATGGAGAAATCTGACAGCATTGCAAACAATAGTATTGTTTGATGTAGTTAACCTTAAGTTATTTTTCAGTAATTTCTTCACAAATCAAGA TTCAAACAGCTTTAAACACTTCCAATGAGATAAAATATTTACTATTATGCTTATTAGAACAAAAGGTGTTTAAGGATGAACTAAATATTT TAATTGAGCATTTATATGGATAATCATACATTATGTAAGCCCATATGTATTTACATCCAGAGTCATAATATTTTAAATAAACAATCATGC >In-frame_ENST00000373701_ENST00000311085_173N_OGT_chrX_70784603_+_DMXL1_chr5_118582689_length(amino acids)=977AA_start in transcript=27_stop in transcript=2960 MKPVTAAAAQALQSIATAAALVLLPPNTFLLVVAAAGPITSFLLSLEKLQMASSVGNVADSTGLAELAHREYQAGDFEAAERHCMQLWRQ EPDNTGVLLLLSSIHFQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLAAALVAAGDME GAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEAKACYLKAIETQPNFAVAWSNLGCVFNAQGEIWLAIHHFEKAVTLDPNFLDAYIN LGNVLKEARIFDRAVAAYLRALSLSPNHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANALKEKGSVAEAEDCYNTAL RLCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQD VQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKN RLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDKFEVFC YALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNELFALRPAPIQAMWLGYPGTSGALFMDYIITD QETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNT ALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQLYKIDPSTLQM -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for OGT-DMXL1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for OGT-DMXL1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for OGT-DMXL1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | OGT | C4478379 | MENTAL RETARDATION, X-LINKED 106 | 3 | GENOMICS_ENGLAND;UNIPROT |
Tgene | DMXL1 | C0017638 | Glioma | 1 | CTD_human |
Tgene | DMXL1 | C0259783 | mixed gliomas | 1 | CTD_human |
Tgene | DMXL1 | C0555198 | Malignant Glioma | 1 | CTD_human |